Madsen, C., Clausen, M. R., Plesner, T. L., Pasanen, A., Kuismanen, T.
, Bentzen, H. H., Jørgensen, J. M., Sillesen, I. B., Himmelstrup, B. M., Rønnov-Jessen, D.
, Jensen, K. R., Pettinger, A. M.
, Ludvigsen, M., Leppä, S.
& d'Amore, F. A. (2018).
Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study.
Blood Advances,
2(13), 1562-1571.
https://doi.org/10.1182/bloodadvances.2018017673
Kharfan-Dabaja, M. A., Kumar, A., Ayala, E., Hamadani, M., Reimer, P., Gisselbrecht, C.
, d'Amore, F., Jantunen, E., Ishida, T., Bazarbachi, A., Foss, F., Advani, R., Fenske, T. S., Lazarus, H. M., Friedberg, J. W., Aljurf, M., Sokol, L., Tobinai, K., Tse, E. ... Savani, B. N. (2017).
Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T-Cell and NK/T-Cell Lymphomas: an International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Biology of Blood and Marrow Transplantation,
23(11), 1826-1838.
https://doi.org/10.1016/j.bbmt.2017.07.027
Bouska, A., Zhang, W., Gong, Q., Iqbal, J., Scuto, A., Vose, J.
, Ludvigsen, M., Fu, K., Weisenburger, D. D., Greiner, T. C., Gascoyne, R. D., Rosenwald, A., Ott, G., Campo, E., Rimsza, L. M., Delabie, J., Jaffe, E. S., Braziel, R. M., Connors, J. M. ... Chan, W. C. (2017).
Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma.
Leukemia,
31(1), 83-91.
https://doi.org/10.1038/leu.2016.175
Rosenberg, C. A., Toft-Petersen, M., Linck, H., Kerndrup, G. B.
, Hokland, P. & Ludvigsen, M. (2017).
Delineating distinct stages of early erythropoiesis in human bone marrow employing imaging flow cytometry. Abstract from Nordic Flow Cytometry Meeting, Copenhagen, Denmark.
Møller, M., Rath, M. F.
, Ludvigsen, M., Honoré, B. & Vorum, H. (2017).
Diurnal expression of proteins in the retina of the blind cone-rod homeobox (Crx(-/-) ) mouse and the 129/Sv mouse: a proteomic study.
Acta Ophthalmologica,
7(95), 717-726.
https://doi.org/10.1111/aos.13429
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Ketterling, R. P., Bedroske, P. P., Luoma, I. M., Sattler, C. A., Boddicker, R. L., Bennani, N. N., Nørgaard, P., Møller, M. B.
, Steiniche, T., d'Amore, F. & Feldman, A. L. (2017).
DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study.
Blood,
130(4), 554-557.
https://doi.org/10.1182/blood-2016-12-755496
Pedersen, M. B., Hamilton Dutoit, S. J., Bendix, K., Ketterling, RP., Bedroske, PP., Luoma, IM., CA, S., Bennani-Baiti, N., Nørgaard, P., Møller, MB.
, Steiniche, T. & d'Amore, F. A. (2017).
First independent validation fo DUSP22 and TP63 rearrangements as outcome predictors in ALK-negative anaplastic large cell lymphoma: a Danish cohort study. Blood.
Holst, J. M., Ludvigsen, M., Hamilton Dutoit, S. J., Bendix, K., Plesner, T. L., Nørgaard, P., Møller, M. B.
, Steiniche, T., Rabinovich, G. A.
, d'Amore, F. A. & Pedersen, M. B. (2017).
High Intratumoral Galectin-1 Is Associated with Adverse Outcome in ALK-Negative, CD30-Positive Peripheral T-Cell Lymphomas.
Blood,
130(Suppl 1), 4079-4079.
Hollander, P.
, Kamper, P., Smedby, K., Enblad, G.
, Ludvigsen, M., Mortensen, J., Amini, RM.
, Hamilton Dutoit, S. J., d'Amore, F. A., Molin, D. & Glimelius, I. (2017).
High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome.
Blood Advances,
1(18), 1427-1439.
https://doi.org/10.1182/bloodadvances.2017006346
Holst, J. M., Plesner, T. L., Pedersen, M. B., Ludvigsen, M., Frederiksen, H., Møller, M. B., Wang, R., Tam, W., Inghirami, G.
& d'Amore, F. A. (2017).
Lympho- and Myeloproliferative Malignancies Occurring in the Same Host: Description of a Nationwide Discovery Cohort.
Blood,
130(Suppl 1), 1525-1525.
Leivonen, S.-K., Icay, K., Jäntti, K., Siren, I., Liu, C., Alkodsi, A., Cervera, A.
, Ludvigsen, M., Hamilton-Dutoit, S. J., d'Amore, F., Karjalainen-Lindsberg, M.-L., Delabie, J., Holte, H., Lehtonen, R., Hautaniemi, S. & Leppä, S. (2017).
MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma.
Blood Cancer Journal,
7(12), 654. Article 654.
https://doi.org/10.1038/s41408-017-0033-8
Vase, M. Ø., Ludvigsen, M., Bendix, K.
, Dutoit, S. H., Hjortebjerg, R., Petruskevicius, I., Møller, M. B., Pedersen, G.
, Denton, P. W., Honoré, B., Rabinovich, G. A.
, Larsen, C. S. & d'Amore, F. (2017).
Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma.
AIDS,
31(16), 2311-2313.
https://doi.org/10.1097/QAD.0000000000001622
Chan, F. C., Mottok, A., Gerrie, A. S., Power, M., Nijland, M., Diepstra, A., van den Berg, A.
, Kamper, P., d'Amore, F., d'Amore, A. L., Hamilton-Dutoit, S., Savage, K. J., Shah, S. P., Connors, J. M., Gascoyne, R. D., Scott, D. W. & Steidl, C. (2017).
Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma.
Journal of Clinical Oncology,
35(32), 3722-3733.
https://doi.org/10.1200/JCO.2017.72.7925
Andersen, M. N., Ludvigsen, M., Abildgaard, N., Petruskevicius, I., Hjortebjerg, R., Bjerre, M., Honoré, B., Møller, H. J. & Andersen, N. F. (2017).
Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation.
OncoTargets and Therapy,
10, 1977-1982.
https://doi.org/10.2147/OTT.S124321
Cederleuf, H.
, Bjerregård Pedersen, M., Jerkeman, M., Relander, T.
, d'Amore, F. & Ellin, F. (2017).
The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study.
British Journal of Haematology,
178(5), 739-746.
https://doi.org/10.1111/bjh.14740
Johnson, P., Federico, M., Kirkwood, A. A., Fossa, A., Berkahn, L., Carella, A.
, d'Amore, F., Enblad, G., Franceschetto, A., Fulham, M. J., Luminari, S., O'Doherty, M. J., Patrick, P., Roberts, T. H., Sidra, G., Stevens, L., Smith, P., Trotman, J., Viney, Z. N. ... Barrington, S. (2016).
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.
The New England Journal of Medicine,
374(25), 2419-2429.
https://doi.org/10.1056/NEJMoa1510093
Kim, S. J., Yoon, D. H., Jaccard, A., Chng, W. J., Lim, S. T., Hong, H., Park, Y., Chang, K. M., Maeda, Y., Ishida, F., Shin, D.-Y., Kim, J. S., Jeong, S. H., Yang, D.-H., Jo, J.-C., Lee, G.-W., Choi, C. W., Lee, W.-S., Chen, T.-Y. ... Kim, W. S. (2016).
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis.
Lancet Oncology,
17(3), 389-400.
https://doi.org/10.1016/S1470-2045(15)00533-1
Snipsøyr, M. G., Ludvigsen, M., Petersen, E., Wiggers, H. & Honoré, B. (2016).
A systematic review of biomarkers in the diagnosis of infective endocarditis.
International Journal of Cardiology,
202, 564-570.
https://doi.org/10.1016/j.ijcard.2015.09.028
Petruskevicius, I., Ludvigsen, M., Hjortebjerg, R., Sørensen, B. S., Kamper, P., Vase, M. Ø., Oestgaard, L. G., Nielsen, B., Honoré, B., Bjerre, M., Rabinovich, G. A.
& d'Amore, F. A. (2016).
Clinical relevance of galectin-1 in hematologic malignancies treated with non-myeloablative hemopoietic stem cell transplantation.
Bone Marrow Transplantation,
51(10), 1387-1390.
https://doi.org/10.1038/bmt.2016.127
Zinzani, P. L., Karlin, L., Radford, J., Caballero, D., Fields, P., Chamuleau, M. E. D.
, d'Amore, F., Haioun, C., Thieblemont, C., González-Barca, E., Grande García, C., Johnson, P. W., van Imhoff, G. W., Ng, T., Dwyer, K. & Morschhauser, F. (2016).
European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma.
Haematologica,
101(10), e407-e410.
https://doi.org/10.3324/haematol.2016.146977
Meier, M., Andersen, K. J., Knudsen, A. R., Ludvigsen, M., Honoré, B. & Mortensen, F. V. (2016).
Extended hepatectomy induces pronounced changes in protein expression levels..
D'Amore, F. A., Relander, T., Lauritzen, G. F., Jantunen, E., Mannisto, S., Meyer, P., Ellin, F.
, Pedersen, M. B. & Toldbod, H. (2016).
Hematopoietic stem-cell transplantation in peripheral T-cell lymphomas. In
Hematopoietic cell transplants - Concepts, controversies and future directions (Vol. 37, pp. 343-347). Cambridge University Press.
https://doi.org/10.3760/cma.j.issn.0253-2727.2016.04.020
Ludvigsen, M., Vase, M. Ø., Bendix, K., Hamilton Dutoit, S. J., Rabinovich, G. A., Møller, M. B., Pedersen, C., Pedersen, G., Obel, N.
, Larsen, C. S. & D'Amore, F. A. (2016).
High Intratumoral Expression of Galectin-1 Correlated with Superior Outcome in HIV-associated DLBCL..
Ludvigsen, M., Vase, M. Ø., Hjortebjerg, R., Petruskevicius, I., Pedersen, C., Pedersen, G.
, Sørensen, B., Bjerre, M., Obel, N.
, Honoré, B., Larsen, C. S. & d'Amore, F. (2016).
Low Serum Galectin-1 Levels Predict Future Lymphoma Development in HIV-Positive Patients.
Blood,
128(22), Article 2945.
Barrington, S. F., Kirkwood, A. A., Franceschetto, A., Fulham, M. J., Roberts, T. H., Almquist, H., Brun, E.
, Hjorthaug, K., Viney, Z. N., Pike, L. C., Federico, M., Luminari, S., Radford, J., Trotman, J., Fosså, A., Berkahn, L., Molin, D.
, D'Amore, F., Sinclair, D. A. ... Johnson, P. W. (2016).
PET-CT for staging & early response: results from 'Response Adapted Therapy in Advanced Hodgkin Lymphoma' (RATHL) (CRUK/07/033).
Blood,
127(12), 1531-1538.
https://doi.org/10.1182/blood-2015-11-679407
Maksten, E. F.
, Vase, M. Ø., Kampmann, J.
, d'Amore, F., Møller, M. B.
, Strandhave, C., Bendix, K., Bistrup, C., Thiesson, H. C.
, Søndergaard, E., Hamilton-Dutoit, S. & Jespersen, B. (2016).
Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study.
Transplant International,
29(4), 483-493.
https://doi.org/10.1111/tri.12744
Vase, M. Ø., Ludvigsen, M., Bendix, K., Hamilton Dutoit, S. J., Møller, M. B., Pedersen, C., Pedersen, G., Obel, N.
, Larsen, C. S., D'Amore, F. A. & Honoré, B. (2016).
Proteomic profiling of pretreatment serum from HIV-infected patients identifies candidate markers predictive of lymphoma development.
AIDS,
30(12), 1889-1898.
https://doi.org/10.1097/QAD.0000000000001152
Lugtenburg, PJ., Brown, P. D. N., Van der Holt, B.
, D'Amore, F. A., Koene, HR., Berenschot, HW., Fijnheer, R., Loosveld, O., Bohmer, LH., Pruijt, H., Verhoef, G., Hoogendoorn, M., de Kan, R., Van Imhoff, GW., van Hooije, C., Lam, KH., de Keizer, B., de Jong, D., Hoekstra, OS. & Zijlstra, JM. (2016).
Randomized phase III study on the effect of early intensification of Rituximab in combination with 2-weekly CHOP chemotherapy flollowed by Rituximab or no maintenance in patients with diffuse large B-cell lymphoma: Results from a HOVON-Nordic Lymphoma Group Study. Abstract from ASCO Annual Meeting, United States.
Clausen, M. R., Leppa, S., Brown, P. D. N., Goerloev, J. S., Panny, M., Willenbacher, W.
, Sillesen, I. B., Segel, E., Bentzen, H. H. N., Thorsgaard, M.
, Pulczynski, E. J., Kamper, P., Gormsen, L. C., Mortensen, J., Lauritzsen, G., Relander, T.
& d'Amore, F. (2016).
The Combination of Pixantrone, Etoposide, Bendamustine and, in CD20+ Tumors, Rituximab (PREBEN) Shows Promising Feasibility/Efficacy in Heavily Pre-Treated Aggressive Lymphomas of B- and T-Cell Phenotype - Results of the Pre-Trial Experience Leading to a Nordic Phase 1/2 Study (the PREBEN Trial).
Blood,
128(22), 1782-1782.
https://doi.org/10.1182/blood-2016-07-726505
Agostinelli, C., Gallamini, A., Stracqualursi, L., Agati, P., Tripodo, C., Fuligni, F., Sista, M. T., Fanti, S., Biggi, A., Vitolo, U., Rigacci, L., Merli, F., Patti, C., Romano, A., Levis, A., Trentin, L., Stelitano, C., Borra, A., Piccaluga, P. P. ... Pileri, S. A. (2016).
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
The Lancet Haematology,
3(10), e467-e479.
https://doi.org/10.1016/S2352-3026(16)30108-9
Johnson, PWM., Federico, M., Kirkwood, AA., Fossa, A., Berkahn, L., Carella, AM.
, D'Amore, F. A., Enblad, G., Franceschetto, A., Fulham, M., Luminari, S., O'Doherty, M., Patrick, P., Roberts, T., Sidra, G., Stevens, L., Smith, P., Trotman, J., Viney, Z. ... Barrington, SF. (2016).
Treatment adaptation guided by interim PET scan in advanced Hodgkin lymphoma.
The New England Journal of Medicine,
374(25), 2419-29.
https://doi.org/10.1056/NEJMoa1510093.
Gang, A. O., Pedersen, M.
, d'Amore, F., Pedersen, L. M., Jensen, B. A.
, Jensen, P., Møller, M. B., Mourits-Andersen, H. T.
, Pedersen, R. S., Klausen, T. W. & de N Brown, P. (2015).
A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry.
Leukemia & Lymphoma,
56(9), 2556-2562.
https://doi.org/10.3109/10428194.2015.1010078
Ludvigsen, M., Kamper, P., Sørensen, B. S., Møller, M. B.
, Bendix, K., Hamilton-Dutoit, S. J., Alsner, J., D'Amore, F. A. & Honoré, B. (2015).
Differential protein expression of peroxiredoxin-1 in classical Hodgkin Lymphoma: a possible correlation to clinical behaviour.
Hematological Oncology,
33, 253-255.
https://doi.org/10.1002/hon.2157
Hansen, G. A. W., Ludvigsen, M., Jacobsen, C., Cangemi, C., Rasmussen, L. M., Vorum, H.
& Honoré, B. (2015).
Fibulin-1C, C1 esterase inhibitor and glucose regulated protein 75 interact with the CREC proteins, calumenin and reticulocalbin.
PLoS One,
10, Article e0132283.
Ludvigsen, M., Madsen, C., Kamper, P., Hamilton-Dutoit, S. J., Bendix, K., D'Amore, F. A. & Honoré, B. (2015).
Histologically transformed follicular lymphoma exhibits protein profiles different from both non-transformed follicular and de novo diffuse large B-cell lymphoma.
Blood Cancer Journal,
5, Article e293.
https://doi.org/10.1038/bcj.2015.18
Vase, M. Ø., Maksten, E. F.
, Strandhave, C., Søndergaard, E., Bendix, K., Hamilton Dutoit, S. J., Andersen, C., Møller, M. B., Sørensen, S. S., Kampmann, J.
, Eiskjær, H., Iversen, M.
, Weinreich, I. D., Møller, B., Jespersen, B. & D'Amore, F. A. (2015).
HLA associations and risk of posttransplant lymphoproliferative disorder in Danish population-based cohort.
Transplantation Direct,
1(7), p e25.
https://doi.org/10.1097/TXD.0000000000000534
Ristolainen, H., Kilpivaara, O.
, Kamper, P., Taskinen, M., Saarinen, S., Leppä, S.
, d'Amore, F. & Aaltonen, L. A. (2015).
Identification of homozygous deletion in ACAN and other candidate variants in familial classical Hodgkin lymphoma by exome sequencing.
British Journal of Haematology,
170(3), 428-431.
https://doi.org/10.1111/bjh.13295
Ristolainen, H., Kilpivaara, O.
, Kamper, P., Taskinen, M., Saarinen, S., Leppä, S.
, D'Amore, F. A. & Aaltonen, L. (2015).
Identification of novel germline variants in early-onset familial classical Hodgkin lymphoma by exome sequencing.
British Journal of Haematology,
170(3), 428-31.
Andersen, R. K., Hammer, K., Hager, H., Christensen, J. N., Ludvigsen, M., Honoré, B., Thomsen, M.-B. & Madsen, M. (2015).
Melanoma tumors frequently acquire LRP2/megalin expression, which modulates melanoma cell proliferation and survival rates. Pigment Cell & Melanoma Research.
https://doi.org/10.1111/pcmr.12352
Vase, M. Ø., Maksten, E. F.
, Bendix, K., Hamilton-Dutoit, S., Andersen, C., Møller, M. B., Sørensen, S. S.
, Jespersen, B., Kampmann, J.
, Søndergård, E., Nielsen, P. S. & D'amore, F. (2015).
Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders.
Leukemia & Lymphoma,
56(6), 1677-85.
https://doi.org/10.3109/10428194.2014.966242
Madsen, C., Pedersen, M. B., Vase, M. Ø., Bendix, K., Møller, M. B., Johansen, P., Jensen, BA., Munksgaard, L., Brown, P. D. N., Segel, E.
& D'Amore, F. A. (2015).
Outcome determinants for transformed indolent lymphomas treated with or without autologous stem cell transplantation. Annals of Oncology,
26(2), 393-9.
https://doi.org/10.1093/annonc/mdu537
Madsen, C., Pedersen, M. B., Vase, M. Ø., Segel, E. K.
, Bendix, K., Jensen, BA., Møller, M. B., Johansen, P., Munksgaard, L., Brown, P. D. N.
& D'Amore, F. A. (2015).
outcome determinats for transformed indolent lymphomas treated with or without autologous stem cell transplantation. Annals of Oncology,
26(2), 393-399.
d'Amore, F., Gaulard, P., Trümper, L., Corradini, P.
, Kim, W.-S., Specht, L., Bjerregaard Pedersen, M., Ladetto, M. & ESMO Guidelines Committee (2015).
Peripheral T-cell Lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of Oncology,
26 Suppl 5, v108-15.
https://doi.org/10.1093/annonc/mdv201